secwatch / observer
8-K filed March 31, 2023, 7:59 PM ET CIK 0001458412
debt confidence high sentiment neutral materiality 0.55

CrossFirst Bankshares raises $7.75M via Series A Preferred Stock at 8% dividend

CROSSFIRST BANKSHARES, INC.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

CROSSFIRST BANKSHARES, INC.: Filed Certificate of Designations establishing Series A Preferred Stock (effective 2023-03-29).

Change
charter amendment
Effective
2023-03-29
Exact text from the filing
On March 29, 2023, the Company filed the Certificate of Designations with the Secretary of State of the State of Kansas, which was effective upon filing.
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

CROSSFIRST BANKSHARES, INC. entered into Purchase Agreement with certain investors qualified as 'accredited investors' valued at aggregate purchase price of $7,750,000 (effective 2023-03-29).

Action
entry
Agreement
equity purchase
Counterparty
certain investors qualified as 'accredited investors'
Value
aggregate purchase price of $7,750,000
Effective
2023-03-29
Exact text from the filing
On March 29, 2023, CrossFirst Bankshares, Inc. (the “Company”) entered into a Securities Purchase Agreement (the "Purchase Agreement") with certain investors qualified as "accredited investors," as such term is defined in Rule 501(a) of Regulation D ("Regulation D") promulgated under the Securities Act of 1933, as amended (the "Securities Act"), pursuant to which the Company offered and sold shares of its Series A Non-Cumulative Perpetual Preferred Stock, par value $0.01 per share (the "Series A Preferred Stock"), for an aggregate purchase price of $7,750,000.
View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR
accession 0001562762-23-000151
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.